References

Unresolved reference

2026 · External reference

Time to revisit the definition and clinical criteria for anaphylaxis

10.1016/j.waojou.2019.100066 · 2019 · External reference

Unresolved reference

2025 · External reference

Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012

10.1111/trf.12918 · 2015 · External reference

Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003

10.1016/j.jaci.2003.12.591 · 2004 · External reference

Epinephrine: the drug of choice for anaphylaxis-a statement of the world allergy organization

10.1097/wox.0b013e31817c9338 · 2008 · External reference

Anaphylactic transfusion reactions associated with anti-IgA antibody

10.1056/nejm196901232800404 · 1969 · External reference

Serologic specificity of human anti-IgA and its significance in transfusion

10.1182/blood.v34.5.573.573 · 1969 · External reference

Non-allergic hypersensitivity reactions to immunoglobulin preparations in antibody deficiencies: What role for anti-IgA IgG and complement activation

10.1007/s12016-024-09007-0 · 2024 · External reference

Allergic transfusion reactions from blood components donated by IgA-deficient donors with and without anti-IgA: a comparative retrospective study

10.1111/j.1423-0410.2010.01326.x · 2010 · External reference

The role of anti-IgA antibodies in causing adverse reactions to gamma globulin infusion in immunodeficient patients: a comprehensive review of the literature

10.1016/j.jaci.2011.06.047 · 2012 · External reference

Unresolved reference

External reference

Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gammaRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis

10.1172/jci119255 · 1997 · External reference

Human IgE-independent systemic anaphylaxis

10.1016/j.jaci.2016.02.015 · 2016 · External reference

Food allergy: transfused and transplanted

10.1007/s11882-010-0110-6 · 2010 · External reference

Anaphylaxis from passive transfer of peanut allergen in a blood product

10.1056/nejmc1101692 · 2011 · External reference

Peanut and fish allergy due to platelet transfusion in a child

10.1503/cmaj.141407 · 2015 · External reference

Passive transfer of peanut hypersensitivity by fresh frozen plasma

10.1001/archinte.167.8.853 · 2007 · External reference

Thrombosis as an intravascular effector of innate immunity

10.1038/nri3345 · 2013 · External reference

The interactions between inflammation and coagulation

10.1111/j.1365-2141.2005.05753.x · 2005 · External reference

Coagulation and sepsis

10.1016/j.thromres.2016.11.007 · 2017 · External reference

Clinical effects and possible mechanisms of transfusion-related immunomodulation

2022 · External reference

Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum

10.1016/j.jaci.2005.12.1343 · 2006 · External reference

Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria

10.1111/j.1398-9995.2009.02222.x · 2010 · External reference

Increase of coagulation potential in chronic spontaneous urticaria

10.1111/j.1398-9995.2010.02506.x · 2011 · External reference

Histamine- or vascular endothelial growth factor-induced tissue factor expression and gap formation between vascular endothelial cells are synergistically enhanced by lipopolysaccharide, tumor necrosis factor-alpha, interleukin (IL)-33 or IL-1beta

10.1111/1346-8138.15516 · 2020 · External reference

Increase of tissue factor expression on the surface of peripheral monocytes of patients with chronic spontaneous urticaria

10.1111/all.14110 · 2020 · External reference

Coagulation factors induce human skin mast cell and basophil degranulation via activation of complement 5 and the C5a receptor

10.1016/j.jaci.2020.08.018 · 2021 · External reference

Increased thrombin generation potential in patients with chronic spontaneous urticaria

10.1016/j.alit.2014.07.006 · 2015 · External reference

Molecular intercommunication between the complement and coagulation systems

10.4049/jimmunol.0903678 · 2010 · External reference

Auxiliary activation of the complement system and its importance for the pathophysiology of clinical conditions

10.1007/s00281-017-0646-9 · 2018 · External reference

Complement activation in arterial and venous thrombosis is mediated by plasmin

10.1016/j.ebiom.2016.02.011 · 2016 · External reference

Complement and coagulation: so close, yet so far

10.1182/blood-2017-10-811943 · 2017 · External reference

Coagulation and complement: Key innate defense participants in a seamless web

10.3389/fimmu.2022.918775 · 2022 · External reference

Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5a

10.1016/j.imlet.2009.10.007 · 2010 · External reference

Function, structure and therapeutic potential of complement C5a receptors

10.1038/sj.bjp.0707332 · 2007 · External reference

Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa

10.1073/pnas.97.10.5255 · 2000 · External reference

Coagulation factor Xa cleaves protease-activated receptor-1 and mediates signaling dependent on binding to the endothelial protein C receptor

10.1111/j.1538-7836.2009.03682.x · 2010 · External reference

Thrombin signalling and protease-activated receptors

10.1038/35025229 · 2000 · External reference

Proteinase-activated receptors

10.1016/s0031-6997(24)01493-5 · 2001 · External reference

PAR1 and PAR2 couple to overlapping and distinct sets of G proteins and linked signaling pathways to differentially regulate cell physiology

10.1124/mol.109.062018 · 2010 · External reference

Structural basis for the activation of proteinase-activated receptors PAR1 and PAR2

10.1038/s41467-025-59138-x · 2025 · External reference

Tryptase and protease-activated receptor-2 stimulate scratching behavior in a murine model of ovalbumin-induced atopic-like dermatitis

10.1016/j.intimp.2015.04.047 · 2015 · External reference

Localization of protease-activated receptors-1 and -2 in human mast cells: indications for an amplified mast cell degranulation cascade

10.3109/10520290009064152 · 2000 · External reference

The role of coagulation and complement factors for mast cell activation in the pathogenesis of chronic spontaneous urticaria

10.3390/cells10071759 · 2021 · External reference

Activation of coagulation, anti-coagulation, fibrinolysis and the complement system in patients with urticaria

2012 · External reference

Evaluation of dysfunction in blood coagulation in children with urticaria

2016 · External reference

Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper

10.1111/all.15889 · 2023 · External reference

Anaphylactic reaction after methylene blue-treated plasma transfusion

10.1093/bja/aer009 · 2011 · External reference

Methylene blue-treated plasma: an increased allergy risk

10.1016/j.jaci.2012.03.050 · 2012 · External reference

Severe anaphylactic reaction after blue dye injection for sentinel lymph node biopsy in breast surgery: Report of two cases and literature review

10.1002/ccr3.3904 · 2021 · External reference

Mast cell degranulation in rat mesenteric venule: effects of L-NAME, methylene blue and ketotifen

10.1006/phrs.1999.0451 · 1999 · External reference

Transfusion-associated adverse reactions (TAARs) and cytokine accumulations in the stored blood components: the impact of prestorage versus poststorage leukoreduction

10.18632/oncotarget.23136 · 2018 · External reference

Kinetics of bradykinin levels during and after leucocyte filtration of platelet concentrates

10.1046/j.1423-0410.1998.7510018.x · 1998 · External reference

Leukocyte filtration fails to limit functional neutrophil activity during cardiac surgery

10.1007/pl00000316 · 2002 · External reference

Long-term leukocyte filtration should be avoided during extracorporeal circulation

10.1155/2013/612848 · 2013 · External reference

Biocompatibility of leukocyte removal filters during bedside leukocyte filtration of red cell concentrates

10.1016/0955-3886(92)90035-f · 1992 · External reference

Effects and side effects of platelet transfusion

10.1055/a-1347-6551 · 2021 · External reference

Pro-inflammatory effects after platelet transfusion: a review

10.1111/vox.12879 · 2020 · External reference

Platelets as cellular effectors of inflammation in vascular diseases

10.1161/circresaha.113.300512 · 2013 · External reference

Expression of complement components and inhibitors on platelet microparticles

10.1080/09537100701777311 · 2008 · External reference

Current understanding of allergic transfusion reactions: incidence, pathogenesis, laboratory tests, prevention and treatment

10.1111/bjh.12150 · 2013 · External reference

Unlocking the non-IgE-mediated pseudo-allergic reaction puzzle with Mas-related G-protein coupled receptor member X2 (MRGPRX2)

10.3390/cells10051033 · 2021 · External reference

MRGPRX2, drug pseudoallergies, inflammatory diseases, mechanisms and distinguishing MRGPRX2- and IgE/FcepsilonRI-mediated events

10.1111/bcp.15845 · 2023 · External reference

Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases

10.1016/j.jaci.2016.04.051 · 2016 · External reference

MRGPRX2 sensing of cationic compounds-a bridge between nociception and skin diseases

10.1111/exd.14222 · 2021 · External reference

The neutrophil alloantigen HNA-3a (5b) is located on choline transporter-like protein 2 and appears to be encoded by an R>Q154 amino acid substitution

10.1182/blood-2009-11-248336 · 2010 · External reference

Transfusion-associated circulatory overload and transfusion-related acute lung injury

10.1182/blood-2018-10-860809 · 2019 · External reference

Choline transporter-like protein-2: New von Willebrand factor-binding partner involved in antibody-mediated neutrophil activation and transfusion-related acute lung injury

10.1161/atvbaha.115.305259 · 2015 · External reference

Anti-endothelial cell antibodies in vasculitis: A systematic review

10.1016/j.autrev.2016.12.012 · 2017 · External reference

Autoimmune aspects of Kawasaki disease

10.18176/jiaci.0300 · 2019 · External reference

The role of autoantibodies in bridging obesity, aging, and immunosenescence

10.1186/s12979-024-00489-2 · 2024 · External reference

Rethinking the role of older donors in a sustainable blood supply

10.1111/trf.18190 · 2025 · External reference

The multifaceted Mas-related G protein-coupled receptor member X2 in allergic diseases and beyond

10.3390/ijms22094421 · 2021 · External reference

Platelet concentrates in platelet additive solutions generate less complement activation products during storage than platelets stored in plasma

10.2450/2022.0323-21 · 2023 · External reference

PAS or plasma for storage of platelets? A concise review

10.1111/tme.12325 · 2016 · External reference

The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment (CME)

10.1111/trf.12498 · 2014 · External reference

Hemostatic function, immunomodulatory capacity, and effects of lipemia in cold-stored whole blood

10.1111/trf.18065 · 2025 · External reference

Storage damage of cold-stored whole blood in CPDA maintenance fluid during the whole effective storage period

10.3389/fcell.2025.1610009 · 2025 · External reference

Danger in the intensive care unit: Damps in critically ill patients

10.1097/shk.0000000000000506 · 2016 · External reference

The role of danger-associated molecular patterns (DAMPs) in trauma and infections

10.21037/jtd.2016.05.22 · 2016 · External reference

Low-grade chronic inflammation: a shared mechanism for chronic diseases

10.1152/physiol.00021.2024 · 2025 · External reference

Source of chronic inflammation in aging

10.3389/fcvm.2018.00012 · 2018 · External reference

Inflammation in obesity, diabetes, and related disorders

10.1016/j.immuni.2021.12.013 · 2022 · External reference

Targeting repair of the vascular endothelium and glycocalyx after traumatic injury with plasma and platelet resuscitation

10.1016/j.mbplus.2022.100107 · 2022 · External reference

Endothelial dysfunction and immunothrombosis in sepsis

10.3389/fimmu.2023.1144229 · 2023 · External reference

Recent advances in laboratory assays for nonhemolytic transfusion reactions

10.1111/j.1537-2995.2009.02388.x · 2010 · External reference

Food and inhaled allergens may play a more prominent role in allergic transfusion reactions than previously recognized

10.1111/trf.18026 · 2024 · External reference

Recent progress in understanding of allergic transfusion reaction

10.1016/j.coi.2025.102644 · 2025 · External reference

The basophil activation test for clinical management of food allergies: Recent advances and future directions

10.2147/jaa.s237759 · 2021 · External reference

Basophil reactivity as biomarker in immediate drug hypersensitivity reactions-potential and limitations

10.3389/fphar.2016.00171 · 2016 · External reference

Clinical utility of a passive immune basophil activation test for the analysis of allergic transfusion reactions

10.1111/trf.14208 · 2017 · External reference

Basophil activation test: Mechanisms and considerations for use in clinical trials and clinical practice

10.1111/all.14747 · 2021 · External reference

IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper

10.1016/j.waojou.2019.100080 · 2020 · External reference

Pilot study on the use of basophil activation tests and skin tests for the prevention of allergic transfusion reactions

10.3389/falgy.2023.1328227 · 2023 · External reference

Point-of-care diagnostics in coagulation management

10.3390/s20154254 · 2020 · External reference